Novartis to spend $300m on biotherapeutics drive
Swiss pharmaceutical company Novartis will create a $100 million biologics hub in Basel as part of a $300 million global investment in biotherapeutics.
Reto Fischer Global Drug Development Head Of Technical Research Division Basel This Technical Research Division Global Drug
Source: swissinfo.ch